Results 131 to 140 of about 3,522 (243)

Topical Ruxolitinib for the Treatment of Alopecia Universalis [PDF]

open access: yesJAMA Dermatology, 2016
Brittany G. Craiglow   +2 more
openaire   +2 more sources

Dupilumab and Alopecia Areata: A Possible Combined or Disturbance Therapy? A Review of The Literature [PDF]

open access: yes
Introduction: Dupilumab, a monoclonal antibody targeting IL-4 receptor subunit alpha, treats atopic dermatitis (AD) and may impact alopecia areata (AA). AA involves Th1-driven immune activity, and recent studies suggest a role for Th2 pathways. Dupilumab’
Brunetti, Tullio   +8 more
core   +1 more source

Successful alopecia universalis treatment with the combination of cyclosporine and oral corticosteroid: a case report

open access: gold, 2022
I Gusti Nyoman Darmaputra   +3 more
openalex   +2 more sources

Alemtuzumab-induced alopecia universalis and transient accommodation spasm in a patient with multiple sclerosis. [PDF]

open access: yesTher Adv Neurol Disord, 2022
Tzanetakos D   +10 more
europepmc   +1 more source

Cutaneous and mucosal manifestations associated with celiac disease [PDF]

open access: yes, 2018
Beteta Gorriti, Valia Patricia   +6 more
core   +2 more sources

Alopecia Areata Universalis during Treatment of Rheumatoid Arthritis with Anti-TNF-α Antibody (Adalimumab)

open access: bronze, 2008
Yuri Nogueira Chaves   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy